CA
Cortland Associates Portfolio holdings
AUM
$857M
This Quarter Return
-0.87%
1 Year Return
+28.7%
3 Year Return
+102.56%
5 Year Return
+155.47%
10 Year Return
+437.52%
AUM
$420M
AUM Growth
+$420M
(-16%)
Cap. Flow
-$76.2M
Cap. Flow
% of AUM
-18.17%
Top 10 Holdings %
Top 10 Hldgs %
80.43%
Holding
42
New
3
Increased
6
Reduced
13
Closed
1
Top Buys
| 1 |
CVS Health
CVS
|
$9.21M |
| 2 |
Cognizant
CTSH
|
$6.98M |
| 3 |
Core Laboratories
CLB
|
$5.88M |
| 4 |
Apple
AAPL
|
$249K |
| 5 |
Emerson Electric
EMR
|
$201K |
Top Sells
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
$59.6M |
| 2 |
Capital One
COF
|
$24.8M |
| 3 |
Idexx Laboratories
IDXX
|
$12.3M |
| 4 |
Visa
V
|
$366K |
| 5 |
Intercontinental Exchange
ICE
|
$327K |
Sector Composition
| 1 | Healthcare | 27.3% |
| 2 | Financials | 19.38% |
| 3 | Technology | 16.74% |
| 4 | Communication Services | 12.31% |
| 5 | Materials | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cognizant
CTSH
$35.3B
| $53.8M | 12.82% | 1,201,130 +155,985 | +15% | +$6.98M |
|
|
2
Visa
V
$683B
| $49.4M | 11.77% | 231,325 -1,715 | -0.7% | -$366K |
|
|
ESRX
3
DELISTED
Express Scripts Holding Company
ESRX
| $38.5M | 9.19% | 545,644 -843,540 | -61% | -$59.6M |
|
4
Alphabet (Google) Class C
GOOG
$2.58T
| $37.4M | 8.91% | 63,897 -421 | -0.7% | -$246K |
|
5
Danaher
DHR
$147B
| $35.2M | 8.4% | 463,889 -2,535 | -0.5% | -$193K |
|
|
6
CVS Health
CVS
$92.8B
| $28.4M | 6.76% | 356,567 +115,767 | +48% | +$9.21M |
|
|
PX
7
DELISTED
Praxair Inc
PX
| $26.2M | 6.25% | 203,145 -649 | -0.3% | -$83.7K |
|
8
eBay
EBAY
$41.4B
| $25.8M | 6.14% | 454,699 -5,047 | -1% | -$286K |
|
|
9
Intercontinental Exchange
ICE
$101B
| $23.5M | 5.6% | 120,457 -1,674 | -1% | -$327K |
|
10
Fastenal
FAST
$57B
| $19.3M | 4.6% | 430,014 -1,132 | -0.3% | -$50.8K |
|
|
MON
11
DELISTED
Monsanto Co
MON
| $17.9M | 4.28% | 159,506 -921 | -0.6% | -$104K |
|
12
Qualcomm
QCOM
$173B
| $15M | 3.59% | 201,241 -2,828 | -1% | -$211K |
|
13
Baidu
BIDU
$32.8B
| $14.2M | 3.39% | 65,159 -939 | -1% | -$205K |
|
|
14
Idexx Laboratories
IDXX
$51.8B
| $11.4M | 2.73% | 97,157 -104,757 | -52% | -$12.3M |
|
15
Aon
AON
$79.1B
| $8.03M | 1.91% | 91,540 -22 | -0% | -$1.93K |
|
|
16
Core Laboratories
CLB
$540M
| $5.88M | 1.4% | +40,162 | New | +$5.88M |
|
17
IBM
IBM
$227B
| $787K | 0.19% | 4,146 | – | – |
|
18
Philip Morris
PM
$260B
| $571K | 0.14% | 6,845 | – | – |
|
19
Pembina Pipeline
PBA
$21.9B
| $503K | 0.12% | 11,939 | – | – |
|
20
Berkshire Hathaway Class B
BRK.B
$1.09T
| $419K | 0.1% | 3,035 | – | – |
|
|
ECYT
21
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $401K | 0.1% | 66,000 +3,000 | +5% | +$18.2K |
|
22
Johnson & Johnson
JNJ
$427B
| $386K | 0.09% | 3,624 +200 | +6% | +$21.3K |
|
23
iShares Russell 1000 ETF
IWB
$43.2B
| $360K | 0.09% | 3,275 | – | – |
|
24
iShares Dow Jones US ETF
IYY
$2.58B
| $359K | 0.09% | 3,625 | – | – |
|
25
Exxon Mobil
XOM
$487B
| $286K | 0.07% | 3,036 +500 | +20% | +$47.1K |
|